Lynch syndrome affects 1 in 279 Americans, increasing cancer risk and highlighting the need for genetic testing and preventive measures. Previvors navigate a complex emotional landscape, balancing ...
Lynch Syndrome (LS) is a common hereditary condition that significantly increases the lifetime risk of developing multiple cancersNOUS-209 is an off-the-shelf cancer immunotherapy designed to induce T ...
Off-the-shelf cancer vaccine specialist Nouscom AG announced positive final results for its lead product, Nous-209, showing there was a “highly potent” and durable immune response in carriers of Lynch ...
Lynch syndrome demands proactive health management, including regular screenings like colonoscopies and endoscopies, to prevent cancer development. Adopting lifestyle habits such as regular exercise, ...
In his doctoral dissertation completed at the University of Jyväskylä, Finland, Tero Sievänen demonstrates that the cancer risk of Lynch syndrome carriers can be assessed based on circulating microRNA ...
September 18, 2006 — Women with endometrial cancer should be screened for genetic mutations indicating Lynch syndrome, say researchers from Ohio State University, in Columbus, who report a study ...
BASEL, Switzerland – January 16, 2026 – Nouscom, a clinical-stage biotech company developing next-generation immunotherapies to treat cancer at all stages, from early cancer interception to late-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results